Attached files
| file | filename |
|---|---|
| EX-99.2 - Advanced Biomedical Technologies Inc. | ex99-2.htm |
| EX-99.1 - Advanced Biomedical Technologies Inc. | ex99-1.htm |
| EX-32.1 - Advanced Biomedical Technologies Inc. | ex32-1.htm |
| EX-31.2 - Advanced Biomedical Technologies Inc. | ex31-2.htm |
| EX-31.1 - Advanced Biomedical Technologies Inc. | ex31-1.htm |
| EX-14.1 - Advanced Biomedical Technologies Inc. | ex14-1.htm |
| EX-10.1 - Advanced Biomedical Technologies Inc. | ex10-1.htm |
| 10-K - Advanced Biomedical Technologies Inc. | form10-k.htm |
Exhibit 32.2
CERTIFICATION
PURSUANT TO
18 U.S.C. Section 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Advanced Biomedical Technologies Inc. (the “Company”) on Form 10-K for the year ended October 31, 2017, as filed with the Securities and Exchange Commission on the date hereof (the “report”), I, Kai Gui, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated this 13th day of February, 2018.
| /s/ Kai Gui | |
| Kai Gui | |
| Director, Secretary, and Chief Financial Officer |